Citadel Advisors’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,500
Closed -$29.6K 13741
2025
Q1
$29.6K Buy
5,500
+2,500
+83% +$18.3K ﹤0.01% 12837
2024
Q4
$25.4K Buy
3,000
+2,400
+400% +$18.9K ﹤0.01% 13019
2024
Q3
$4.02K Buy
600
+500
+500% +$3.24K ﹤0.01% 13600
2024
Q2
$683 Sell
100
-200
-67% -$1.47K ﹤0.01% 13933
2024
Q1
$2.57K Sell
300
-2,800
-90% -$26.3K ﹤0.01% 13993
2023
Q4
$32.7K Buy
3,100
+1,800
+138% +$17.7K ﹤0.01% 12199
2023
Q3
$12.5K Sell
1,300
-1,700
-57% -$17.4K ﹤0.01% 12960
2023
Q2
$28.9K Sell
3,000
-15,000
-83% -$136K ﹤0.01% 12394
2023
Q1
$140K Buy
18,000
+8,000
+80% +$73.7K ﹤0.01% 10760
2022
Q4
$86.8K Buy
+10,000
New +$81.5K ﹤0.01% 11412
2022
Q2
Sell
-25,500
Closed -$250K 13458
2022
Q1
$250K Sell
25,500
-29,700
-54% -$382K ﹤0.01% 10998
2021
Q4
$940K Buy
55,200
+14,800
+37% +$235K ﹤0.01% 8120
2021
Q3
$526K Buy
+40,400
New +$659K ﹤0.01% 9737

Other funds holding INFU

Citadel Advisors's INFU Position: Q1 2026 in Review

Citadel Advisors increased its InfuSystem Holdings (INFU) stake by 144% in Q1 2026, buying an estimated $875K and bringing the position to 169,954 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #6619.

Citadel Advisors first reported a position in INFU in Q3 2013 and has held it in 26 quarters since. The position peaked at $2.19M in Q2 2025. 96 funds tracked by Wall St. Rank hold INFU as of Q1 2026.

  • Citadel Advisors held 169,954 shares of InfuSystem Holdings worth $1.57M as of Q1 2026.
  • Citadel Advisors bought 100,238 InfuSystem Holdings shares in Q1 2026, an estimated $875K.
  • InfuSystem Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6619 holding.
  • Citadel Advisors first reported a position in InfuSystem Holdings in Q3 2013 and has held it in 26 quarters since.
  • Citadel Advisors's InfuSystem Holdings position peaked at $2.19M in Q2 2025.
  • 96 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.